![]() |
Volumn 75, Issue 2, 1995, Pages 157-160
|
Life expectancy in the Marfan syndrome
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
a,b,c,d
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
METOPROLOL;
NADOLOL;
PROPRANOLOL;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR SURGERY;
CAUSE OF DEATH;
COHORT ANALYSIS;
FEMALE;
HUMAN;
LIFE EXPECTANCY;
LIFE TABLE;
LIFESPAN;
MAJOR CLINICAL STUDY;
MALE;
MARFAN SYNDROME;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
ADULT;
CARDIOVASCULAR DISEASES;
CHILD;
FEMALE;
HUMAN;
LIFE EXPECTANCY;
MALE;
MARFAN SYNDROME;
SCOTLAND;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL ANALYSIS;
UNITED STATES;
|
EID: 0028854314
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(00)80066-1 Document Type: Article |
Times cited : (520)
|
References (18)
|